Platelet inhibition assessed with VerifyNow, flow cytometry and PlateletMapping in patients undergoing heart surgery

Thrombosis Research

Volumn 124, Issue 5, 2009, Pages 572-577

  Alström, Ulrica ^a   Granath, Fredrik ^b   Oldgren, Jonas ^a   Ståhle, Elisabeth ^a   Tydén, Hans ^c   Siegbahn, Agneta ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

aspirin; clopidogrel; heart surgery; platelet function test

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE RECEPTOR; APROTININ; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; PADGEM PROTEIN; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING TENDENCY; CELL STIMULATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BLOCKING; RISK ASSESSMENT; SURGICAL RISK; THROMBOCYTE AGGREGATION INHIBITION; THROMBOELASTOGRAPHY;

AGED; CELL ADHESION MOLECULES; CORONARY ARTERY BYPASS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; PHOSPHOPROTEINS; PHOSPHORYLATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PLATELET TRANSFUSION; TREATMENT OUTCOME;

EID: 70349880511     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.06.024     Document Type: Article

References (31)

1. Mehta R.H., Roe M.T., Mulgund J., Ohman E.M., Cannon C.P., Gibler W.B., et al. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. J Am Coll Cardiol 48 (2006) 281-286
2. Steinhubl S.R., Berger P.B., Mann III J.T., Fry E.T., De Lago A., Wilmer C., et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288 (2002) 2411-2420
3. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., and Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
4. Chen Z.M., Jiang L.X., Chen Y.P., Xie J.X., Pan H.C., Peto R., et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 (2005) 1607-1621
5. Wallentin L., Varenhorst C., James S., Erlinge D., Braun O.O., Jakubowski S.A., et al. Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease. Eur Heart J 29 (2008) 21-30
6. Kapetanakis E.I., Medlam D.A., Boyce S.W., Haile E., Hill P.C., Dullum M.K., et al. Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?. Eur Heart J 26 (2005) 576-583
7. Ouattara A., Bouzguenda H., Le Manach Y., Leger P., Bonnet N., Montalesot G., et al. Impact of aspirin with or without clopidogrel on postoperative bleeding and blood transfusion in coronary surgical patients treated prophylactically with a low-dose of aprotinin. Eur Heart J 28 (2007) 1025-1032
8. Braunwald E., Antman E.M., Beasley J.W., Califf R.M., Cheitlin M.D., Hochman J.S., et al. Jr ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 40 7 (2002) 1366-1374
9. Ferraris V.A., Ferraris S.P., Saha S.P., Hessel E.A., Haan C.K., Royston B.D., et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 83 (2007) S27-86
10. Dunning J., Versteegh M., Fabbri A., Pavie A., Kohl P., Lockowandt U., et al. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 34 (2008) 73-92
11. Bonello L., Paganelli F., Arpin-Bornet M., Auquier P., Sampol J., Dignat-George F., et al. Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events. J Thromb Haemost 5 (2007) 1630-1636
12. Bonello L., Camoin-Jau L., Arques S., Boyer C., Panagides D., Wittenberg O., et al. Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study. J Am Coll Cardiol 51 (2008) 1404-1411
13. Blindt R., Stellbrink K., de Taeye A., Muller R., Kiefer P., Yagmur E., et al. The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis. Thromb Haemost 98 (2007) 1329-1334
14. Schwarz U.R., Geiger J., Walter U., and Eigenthalter M. Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets-definition and detection of ticlopidine/clopidogrel effects. Thromb Haemost 82 (1999) 1145-1152
15. Malinin A., Pokov A., Spergling M., Defranco A., Schwartz K., Schwartz D., et al. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study. Thromb Res 119 (2007) 277-284
16. Craft R.M., Chavez J.J., Bresee S.J., Wortham D.C., Cohen E., and Carroll R.C. A novel modification of the Thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med 143 (2004) 301-309
17. Aleil B., Ravanat C., Cazenave J.P., Rouchoux G., Heitz A., and Gachet C. Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost 3 (2005) 85-92
18. Alstrom U., Tyden H., Oldgren J., Siegbahn A., and Stahle E. The platelet inhibiting effect of a clopidogrel bolus dose in patients on long-term acetylsalicylic acid treatment. Thromb Res 120 (2007) 353-359
19. Colton T. Regression and Correlation. In: Statistics in medicine: Little,Brown and Company Boston (1974) 211
20. Kapetanakis E.I., Medlam D.A., Petro K.R., Haile E., Hill P.C., Dullum M.K., et al. Effect of clopidogrel premedication in off-pump cardiac surgery: are we forfeiting the benefits of reduced hemorrhagic sequelae?. Circulation 113 (2006) 1667-1674
21. Hongo R.H., Ley J., Dick S.E., and Yee R.R. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol 40 (2002) 231-237
22. Ascione R., Ghosh A., Rogers C.A., Cohen A., Monk C., and Angelini G.D. In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: a word of caution. Ann Thorac Surg 79 (2005) 1210-1216
23. Price M.J., Coleman J.L., Steinhubl S.R., Wong G.B., Cannon C.P., and Teirstein P.S. Onset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers. Am J Cardiol 98 (2006) 681-684
24. Fergusson D.A., Hebert P.C., Mazer C.D., Fremes S., MacAdams C., Murkin J.M., et al. Comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358 (2008) 2319-2331
25. Despotis G.J., and Goodnough L.T. Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery. Ann Thorac Surg 70 (2000) S20-32
26. Ballotta A., Saleh H.Z., El Baghdady H.W., Gomaa M., Belloli F., Kandil H., et al. Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery. J Thorac Cardiovasc Surg 134 (2007) 132-138
27. Mengistu A.M., Wolf M.W., Boldt J., Rohm K.D., Lang J., and Piper S.N. Evaluation of a new platelet function analyzer in cardiac surgery: a comparison of modified thromboelastography and whole-blood aggregometry. J Cardiothorac Vasc Anesth 22 (2008) 40-46
28. Michelson A.D. P2Y12 antagonism: promises and challenges. Arterioscler Thromb Vasc Biol 28 (2008) s33-8
29. Frere C., Cuisset T., Quilici J., Camoin L., Carvaj J., Morange P.E., et al. ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome. Thromb Haemost 98 (2007) 838-843
30. Morel O., Faure A., Ohlmann P., Jesel L., Desprez D., Grunebaum L., et al. Impaired platelet responsiveness to clopidogrel identified by flow cytometric vasodilator-stimulated phosphoprotein (VASP) phosphorylation in patients with subacute stent thrombosis. Thromb Haemost 98 (2007) 896-899
31. Gurbel P.A., Bliden K.P., Samara W., Yoho J.A., Hayes K., Fissha M.Z., et al. Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study. J Am Coll Cardiol 46 (2005) 1827-1832